Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase - Test2 - elhamkhani - TriplyDB

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

http://www.wikidata.org/entity/Q24555807

about

Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugs Development of highly sensitive fluorescent assays for fatty acid amide hydrolase Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity Brain monoglyceride lipase participating in endocannabinoid inactivation Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury Novel bioactive metabolites of dipyrone (metamizol)The endocannabinoid system as a target for the treatment of cannabis dependence The endocannabinoid system as an emerging target of pharmacotherapy A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol The elmiric acids: biologically active anandamide analogs Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning Endocannabinoids in the retina: from marijuana to neuroprotection Organophosphate-sensitive lipases modulate brain lysophospholipids, ether lipids and endocannabinoids Anandamide and vanilloid TRPV1 receptors Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes Evidence against the presence of an anandamide transporter Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS Chemical probes of endocannabinoid metabolism Cannabinoids as therapeutic agents in cancer: current status and future implications Therapeutic potential of monoacylglycerol lipase inhibitors The pharmacological landscape and therapeutic potential of serine hydrolases GPCRs in stem cell function TRPV1 in brain is involved in acetaminophen-induced antinociception Endocannabinoids control platelet activation and limit aggregate formation under flow Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways Structure-guided inhibitor design for human FAAH by interspecies active site conversion Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain Initial insight into the function of the lysosomal 66.3 kDa protein from mouse by means of X-ray crystallography Crystal Structure of Fatty Acid Amide Hydrolase Bound to the Carbamate Inhibitor URB597: Discovery of a Deacylating Water Molecule and Insight into Enzyme Inactivation Reversible Competitive α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Containing Additional Conformational Constraints in the Acyl Side Chain: Orally Active, Long-Acting Analgesics Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH)A Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide Hydrolase Rational Design of Fatty Acid Amide Hydrolase Inhibitors That Act by Covalently Bonding to Two Active Site Residues Crystallographic study of FABP5 as an intracellular endocannabinoid transporter Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation

P2860

Q21090462-755185FB-3823-4CE8-A303-2552CCBD8C8B Q21090833-2C8BF948-9250-44C6-9DFA-EB02748B0A26 Q23913685-493DC686-9761-4F36-9AF5-9BBF8BDCB274 Q24523292-2EDB0712-B905-419C-8A5E-EAA8D0B3B5B6 Q24533828-22F407BC-1C78-41E8-9945-E4E4C1A97840 Q24569799-539EE006-0483-4815-A804-E579E10822E2 Q24595633-F49CCE92-4713-46D9-BE8C-F0F3E808CDE6 Q24616603-0E5D52B2-543E-4720-A3B5-AAFE7B63BF0E Q24648135-06D96F06-A289-4ED0-87CF-ADDCC82ABEE5 Q24648473-48A7F764-97B1-4EBF-ACBA-13C69EF4E82F Q24649418-A5A1DA7B-18C1-42F9-BAE0-5535D7BC7FAF Q24650559-E6E95374-274A-4D64-A00A-5B37AB36D9A9 Q24650912-312BA39A-76A2-463A-A917-315F70E435E6 Q24656049-754B83E0-0D2A-48A3-BF2A-F968C5886CD3 Q24658124-53E01962-C2D8-45F8-8254-623D6FE1F75F Q24672354-B00BE9F5-822F-4ECD-AB51-E9A2B219423A Q24680497-7C068EAC-4327-406B-9303-DB898159F516 Q24680869-073631B7-791E-44EC-AEDC-2C9CCFC3CBC6 Q24683153-0431C6EE-FCEB-4801-A2F6-C2225E2BA5AA Q26777055-F19509FB-47E4-4D5D-B6B7-F5977F0F57BC Q26853436-FFDC4BBF-FFC5-48F9-A74A-FB2F73389388 Q26863202-554F0FA3-4C69-4725-B12D-E8CFA76A98ED Q26866298-E5E7774A-0569-4E0E-ABB4-8A31271B2ECD Q26991513-C4269B52-82CD-4C56-B850-BDF10D321102 Q26995817-D36E2733-B9BC-4F47-9FF7-1567FFC3E770 Q27003270-31BAACF2-61DD-4C79-9DCD-8323DABA9E1B Q27320173-57783C6A-D7BB-40BB-9CE6-9E8A18A32749 Q27345221-1D39FE1F-CF84-49B6-B6C6-66434E3280BD Q27345385-7F047A8D-26E4-42C2-8C56-9C71F9A84324 Q27496303-099B5A64-8732-4AE5-897C-C88FE84DCC18 Q27651822-AC2F1D5B-BCA4-4387-B6FE-16AF01DC13DF Q27655121-56C44662-6074-4F97-A493-E0B5D1FAD489 Q27657154-D1564C65-3BEF-4041-BFC0-56C2BE86EA32 Q27661834-606C7848-90EB-458B-AD89-A8549D969B60 Q27667312-EEEDCB5C-6CFD-46CF-9F25-8CBF13E936D6 Q27667550-E6B7467A-CB15-41F4-B23C-9D4CC298473B Q27675504-343D81DF-08A5-4602-B1D6-003A5C26BB6C Q27677344-2DC5D9CC-4833-4BCA-A2D7-7BDA162E0CE4 Q27681752-BBA8EF17-6119-49E9-B6C4-FF3510D1C0AD Q28066215-BD12BFAB-ACB4-4FA3-A6ED-047ADB917F0A

P2860

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

http://www.wikidata.org/entity/Q24555807

description

2001 nî lūn-bûn

@nan

2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Supersensitivity to anandamide ...... ing fatty acid amide hydrolase

@ast

Supersensitivity to anandamide ...... ing fatty acid amide hydrolase

@en

Supersensitivity to anandamide ...... ing fatty acid amide hydrolase

@nl

type

label

Supersensitivity to anandamide ...... ing fatty acid amide hydrolase

@ast

Supersensitivity to anandamide ...... ing fatty acid amide hydrolase

@en

Supersensitivity to anandamide ...... ing fatty acid amide hydrolase

@nl

prefLabel

Supersensitivity to anandamide ...... ing fatty acid amide hydrolase

@ast

Supersensitivity to anandamide ...... ing fatty acid amide hydrolase

@en

Supersensitivity to anandamide ...... ing fatty acid amide hydrolase

@nl

P1433

Q24555807-95670477-78A2-41AD-B66E-990915265EAE

P1476

Q24555807-05D5549C-14D4-4660-A1CA-106D413BB9A0

P2093

Q24555807-10C38823-D495-4CCB-A007-0A047070340C

Q24555807-6A2C0349-B41E-40BC-A83A-974DE97D3245

Q24555807-7C3BCEB8-1775-44BB-8FED-02084FE9A1E7

Q24555807-9F083C4C-BA8F-42EC-AFCA-6A1FFB8ED81C

Q24555807-AC5D6CB2-AA8A-4F19-8824-3F40A8CCFAA2

Q24555807-DD9AC429-FE33-45D9-87F9-5600FFB97771

P2860

Q24555807-0CF80CC4-F086-4D30-8FD4-894EE184F1C5

Q24555807-15C23C1A-4CE5-4601-A1DB-165359F014C4

Q24555807-2C7208D9-C7B7-4BA7-9D6E-4AD92A180E23

Q24555807-2E6D8613-814A-44FA-BB6D-4F48296BAE4A

Q24555807-2FE4A4BC-0C0B-48ED-A878-682B10287F9A

Q24555807-329DDD9E-57E1-421E-8AE5-B2A28CC49951

Q24555807-3A679815-B984-4D6D-B456-EBDCC19CD1C1

Q24555807-3F4A0725-6F61-449C-ADF8-42DA1A2D18A8

Q24555807-42B5BBCF-EE5C-4FF9-A8D1-6708EFF44D57

Q24555807-4654D605-9E89-417B-8199-7FCB63E9614E

P304

Q24555807-79EB6A35-A9BA-4CA0-83CF-7E1DBE58ED51

P31

Q24555807-6DCBBBD0-9533-44F0-983F-C179C4E730D5

P3181

Q24555807-B7C13283-627A-4F0C-9D90-763EDB870283

P356

Q24555807-D3AC6C57-B08B-40E5-BB6C-A4EEBE36319A

P407

Q24555807-431B5F8B-3261-46F0-9EAB-FA5E92CAC1A1

P433

Q24555807-A2BDE2D6-1EF6-4977-9484-8EB575B4B158

P478

Q24555807-C9A49974-595F-4212-BD08-672F82271E28

P50

Q24555807-2103DB2C-9E6E-435E-B2BE-48E79032E499

P577

Q24555807-E6981735-B8C3-4BE5-A1E8-97759F823A68

P5875

Q24555807-5FC55D92-E25D-4ACA-B27A-F7DD9B5D0538

P698

Q24555807-CF14D0CE-687B-47B5-81D0-6A882F22ECE4

P921

Q24555807-382D7982-F65B-43DA-A205-5EA0786DADEE

Q24555807-BA08A226-EB86-44B1-BA63-34558D0B08D3

Q24555807-E28AE5D6-FB8C-480F-9A44-6F347271F43B

P932

Q24555807-462C1691-30E1-402E-9102-45740583A923

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Supersensitivity to anandamide ...... ing fatty acid amide hydrolase

@en

P2093

A H Lichtman

http://www.w3.org/2001/XMLSchema#string

B F Cravatt

http://www.w3.org/2001/XMLSchema#string

D K Giang

http://www.w3.org/2001/XMLSchema#string

K Demarest

http://www.w3.org/2001/XMLSchema#string

M H Bracey

http://www.w3.org/2001/XMLSchema#string

M P Patricelli

http://www.w3.org/2001/XMLSchema#string

P2860

Initial sequencing and analysis of the human genome

The Sequence of the Human Genome

Molecular characterization of human and mouse fatty acid amide hydrolases

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

Chemical characterization of a family of brain lipids that induce sleep

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

P304

9371-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

796146

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.161191698

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

P577

2001-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11871467

http://www.w3.org/2001/XMLSchema#string

P698

11470906

http://www.w3.org/2001/XMLSchema#string

P921

P932

55427

http://www.w3.org/2001/XMLSchema#string